Narrative review outlines essential patient education strategies for oncology pharmacists, suggesting personalized approaches for anticancer therapy delivery.
Educating patients and caregivers on anticancer therapy is central to oncology pharmacy practice. As anticancer regimens become more complex, oncology pharmacists need a structured framework that ensures vital information is communicated and personalized to each patient. Though existing organizational guidelines, largely written for nurses, and standards for oral oncolytic therapy counseling provide valuable insight, a dedicated guideline for oncology pharmacists regarding the delivery of patient education for parenteral and combination anticancer therapies is largely bereft. This review addresses that gap, presenting a pharmacist‐led model that encompasses the pre‐visit assessment, preparation, step‐by‐step delivery of the teaching session, and practical considerations for maximizing patient understanding and safety. This narrative review summarizes evidence for effective patient education on parenteral anticancer therapies. The authors propose a structured framework for oncology pharmacist‐led patient education on parenteral anticancer therapies that combines pharmacotherapy knowledge and the application of patient‐centered care.
No takes yet. Share an insight, caveat, or question.
Hickey et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: